Revive Therapeutics Ltd C.RVV

Trial update

[1ottrunner]

One new site
https://clinicaltrials.gov/ct2/history/NCT04504734?A=21&B=22&C=merged#StudyPageTop

[1ottrunner]

and their studies page, which does not include this study, just one copd trial: https://www.nurenmedical.com/volunteer

[TheTerminator1]

Thanks for posting it..Thanks

[1ottrunner]

I expect the trial is very close or has passed 400 participants. Just 22 patients per site would get it to 1000 patients. 60 days tops.

[TheTerminator1]

We will all be celebrating soon Big Guy RVV would not be spending Millions and Millions for nothing,yjey know Bucillamine is a winner.... Keep in mind that Bucillamine will also be used for other nasty viruses :) Long and strong 

[MyAli4s]

This post has been removed in accordance with Community Policy

[TheTerminator1]

I hope you are trying to give it any negative spin...RVV knows it works!

[1ottrunner]

Term, every single trial in the world costs millions and about half fail Phase 3. Oncyolitic trials are just 15% successful and Billions are spent exploring new therapies. They do not KNOW bucillamine is a winner.  They think the method of action will prove successful and it looks great, but Bill Gates thought the same of Colchicine, whihc had the same method of action (less potent in a

[Towser7]

Completely agree.  I worry that even positive results will have an underwhelming impact on SP.  whether that's because it's too late or just not properly covered/promoted it is a fear.  

[1ottrunner]

Positive results would have a great impact on SP, I would not be surprised to see $2.  The chance of seeing positive results based on what the Colchicine trial put up, with the same method of action?  20% is gracious. If the trial is successful the news will be picked up nationally.

[TheTerminator1]

Once RVV's SP reaches $2,will it become marginable?

[1ottrunner]

On the OTC?  lol

[TheTerminator1]

It will not remain on the OTC much longer

[1ottrunner]

ahhh...I think it will remain on the OTC until RVV sorts out the, I can't remember the total so I'll guess, 800k it has owing to a creditor. This is a faint memory so the totals and reasons are blurry but the company does have, again foggy, a court settlement or case active against it. So, ya, that is the holdup there.  IMO

[1ottrunner]

This:   The Company is in dispute with a supplier over invoices in the amount of $827,574 plus interest for which the supplier has sought arbitration. The dispute is in arbitration. No provision has been set up in the accounts of the Company. Any settlement and/or payment will be accounted for in the year it occurs. Readers are cautioned that the eventual resolution of this liability

[1ottrunner]

Sorry, you mean uplist to the NAS? That isn't going to happen with a consolidation.